设为首页 加入收藏

Ireland[爱尔兰药品]

XIFAXANTA 200 mg Film-coated Tablets
1.Nameofthemedicinalproduct ▼Xifaxanta200mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Onefilm-coatedtabletcontains: Rifaximin200mg Excip..
录入者:admin       发表于:2014-09-28            查阅全文...
Xylocaine 2% with Adrenaline (Epinephrine) (1:200 000) Solut
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2014-09-27            查阅全文...
Xylocaine 10 mg/delivered dose Mucosal SprayLidocaine
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2014-09-27            查阅全文...
XIFAXANTA 200 mg Film-coated Tablets
1.Nameofthemedicinalproduct ▼Xifaxanta200mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Onefilm-coatedtabletcontains: Rifaximin200mg Excip..
录入者:admin       发表于:2014-09-26            查阅全文...
Sprycel 20mg, 50mg, 80mg, 100mg and 140mg Film Coated Tablets
1.Nameofthemedicinalproduct SPRYCEL®20mgfilm-coatedtablets SPRYCEL®50mgfilm-coatedtablets SPRYCEL®80mgfilm-coatedtablets SPRYCEL®100mgfilm-coatedtablets..
录入者:admin       发表于:2014-09-23            查阅全文...
PARIET 10 mg and 20 mg gastro-resistant tablet.Rabeprazole S
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2014-09-22            查阅全文...
Elonva 100 and 150 micrograms solution for injection
1.Nameofthemedicinalproduct Elonva100and150microgramssolutionforinjection. 2.Qualitativeandquantitativecomposition Elonva100microgramssolutionforinjection Each..
录入者:admin       发表于:2014-09-21            查阅全文...
VESANOID10 mg soft capsulesTretinoin
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2014-09-18            查阅全文...
Fludara oral 10 mg film-coated tabletsFludarabine Phosphate
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-17            查阅全文...
ORENCIA 250 mg powder for concentrate for solution for infusion
1.Nameofthemedicinalproduct ORENCIA250mgpowderforconcentrateforsolutionforinfusion. 2.Qualitativeandquantitativecomposition Eachvialcontains250mgofabatacept. Eachmlco..
录入者:admin       发表于:2014-09-17            查阅全文...
VPRIV 400 Units powder for solution for infusionVelagluceras
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-16            查阅全文...
Palexia 75 mg film-coated tabletsTapentadol hydrochloride
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia 50 mg film-coated tabletsTapentadol hydrochloride
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia SR 50 mg prolonged-release tabletsTapentadol hydroch
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia SR 200 mg prolonged-release tabletsTapentadol hydroc
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia SR 100 mg prolonged-release tabletsTapentadol hydroc
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia SR 250 mg prolonged-release tabletsTapentadol hydroc
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia SR 150 mg prolonged-release tabletsTapentadol hydroc
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia 50 mg 75 mg film-coated tablets
1.Nameofthemedicinalproduct PALEXIA®50mgfilm-coatedtablets PALEXIA®75mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachfilm-coatedtablet..
录入者:admin       发表于:2014-09-14            查阅全文...
Palexia SR 50, 100, 150, 200, 250 mg prolonged-release tablets
PalexiaSR(forseverechronicpain)isthebrandnamefortapentadolprolongedrelease,whichisastrongpainkillerindicatedformanagementofseverechronicpaininadults,whichcanbeadequatelymanagedwithopioidanalgesi..
录入者:admin       发表于:2014-09-14            查阅全文...

相关栏目

热门文章

推荐文章

广告位